Genomic Insights for Medication Response

CAP Accredited College of American Pathologists logo with a dotted circle and a checkmark.

Tenacity+ Genomic Solutions is a CAP-accredited precision genomics organization focused on advancing pharmacogenomics (PGx)–based insights and clinical decision support. We help clinicians, researchers, and partners better understand how genetic variation may influence medication metabolism, response, and tolerability.

Our services are designed to support education, research, and informed clinical discussion—not to diagnose disease or direct medical treatment.y decision we make is shaped by a clear sense of purpose. Our journey has been anything but ordinary. Through every step, we've focused on staying true to our values and making space for thoughtful, lasting work.

Educational

Informational

Non-Diagnostic

Educational Informational Non-Diagnostic

The benefits physicians and patients see when utilizing One Tenacity PGx Testing

Physicians are increasingly being asked to make complex prescribing decisions with limited time and incomplete insight into how each patient may respond to medication. Pharmacogenetic (PGx) testing adds a valuable layer of clarity by helping identify how a patient is likely to metabolize and respond to commonly prescribed drugs, supporting more informed treatment choices from the start. Working with us means having a reliable partner who provides clear, clinically relevant reports that are easy to interpret and integrate into everyday practice. This can help reduce trial-and-error prescribing, lower the risk of adverse drug reactions, and strengthen patient trust by showing a more personalized approach to care. Ultimately, PGx testing supports better patient outcomes while helping physicians practice with greater confidence and precision.

Close-up of a glowing DNA helix with pink and blue lights against a dark background.

What Is Pharmacogenomics (PGx)?

Pharmacogenomics (PGx) is the study of how genetic differences can influence the way individuals process and respond to medications. Scientific evidence has shown that certain genetic variants may affect drug metabolism, transport, and sensitivity, contributing to variability in efficacy and adverse effects.

PGx insights can help support thoughtful, individualized medication discussions when used alongside clinical judgment and other patient-specific factors.

Two people standing in front of a whiteboard filled with sketches, diagrams, and notes, one holding a laptop and the other a marker.

What Tenacity+ Provides

Tenacity+ focuses on the development and delivery of high-quality genetic information and interpretive insights related to medication response.

Our work includes:


Targeted gene profiling related to drug metabolism and transport

01

Evidence-based interpretation grounded in peer-reviewed literature

02

Structured genomic insights to support education and clinical discussion

03

Support for research, innovation, and healthcare professional learning

04

All outputs are non-diagnostic and are not intended to replace clinical assessment or medical decision-making.

Who We Support

Tenacity+ collaborates with healthcare professionals and partners across multiple care areas where medication optimization and polypharmacy considerations are common, including:

Our goal is to help stakeholders integrate
genomic awareness into patient-centered
conversations responsibly and compliantly.

Mental health and psychiatry

Primary care and internal medicine

Oncology and specialty care

Pain management

Chronic disease management

Who we are

  • Tenacity+ operates within a robust quality framework and maintains CAP accreditation, reflecting our commitment to analytical rigor, data integrity, and continuous quality improvement.

    CAP accreditation supports our internal quality systems and processes; it does not replace or supersede provincial laboratory licensing requirements.

  • At Tenacity+, we are committed to making genomic-guided healthcare accessible, responsible, and clinically meaningful—supporting healthcare professionals as they explore personalized approaches to medication management informed by genetics.

No ordering, no testing,
no patient claims